Company

NKT Therapeutics, Inc

NKT Therapeutics develops immunotherapies targeting natural killer T cells for cancer and autoimmune diseases.

About

Founded in 2008 and based in Waltham, Massachusetts, NKT Therapeutics develops immunotherapies targeting natural killer T cells for cancers and autoimmune diseases. The company raised USD 2 million in a Series A round in February 2013. It has completed four deals.

2Funding rounds

2Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in